Usage, Warranty and Licenses Oligonucleotides and nucleic acid products are manufactured and sold by IDT for the customer's research purposes only. Resale of IDT products requires the express written consent of IDT. Unless pursuant to a separate signed agreement by authorized IDT officials, IDT products are not sold for (and have not been approved) for use in any clinical, diagnostic or therapeutic applications. Obtaining license or approval to use IDT products in proprietary applications or in any non-research (clinical) applications is the customer's exclusive responsibility. IDT will not be responsible or liable for any losses, costs, expenses or other forms of liability arising out of the unauthorized or unlicensed use of IDT products. Purchasers of IDT products shall indemnify and hold IDT harmless for any and all damages and/or liability, however characterized, related to the unauthorized or unlicensed use of IDT products. Under no circumstances shall IDT be liable for any consequential damages, resulting from any use (approved or otherwise) of IDT products. All orders received by IDT, and all sales of IDT products are made subject to the aforementioned use restrictions and customer indemnification of IDT. IDT's products are guaranteed to meet or exceed our published specifications for identity, purity and yield as measured under normal laboratory conditions. If our product fails to meet such specifications, IDT will promptly replace the product. All other warranties are hereby expressly disclaimed, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose, and any warranty that the products, or the use of products, manufactured by IDT will not infringe the patents of one or more third-parties. All orders received by IDT, and all sales of IDT products are made subject to the aforementioned use restrictions and customer indemnification of IDT. * Fluorescent Labeled Oligonucleotides  | Alexa Fluor® / Texas Red® / Bodipy® / Rhodamine Red™ and Rhodamine Green™ are provided under an agreement between Molecular Probes, Inc (a wholly owned subsidiary of Invitrogen Corporation), and Integrated DNA Technologies, and the manufacture, use, sale or import of this product may be subject to one or more U.S patents, pending applications, and corresponding non-U.S. equivalents, owned by Molecular Probes, Inc. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The buyer cannot sell or otherwise transfer (a) this product (b) its components or (c) materials made using this product o its components to a third party or otherwise use this product or its components or materials made using this product or its components for Commercial Purposes. Commercial Purposes means any activity by a party for consideration and may include, but is not limited to: (1) use of the product or its components in manufacturing; (2) use of the product or its components to provide a service, information, or data; (3) use of the product or its components for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product or its components, whether or not such product or its components are resold for use in research. For information on purchasing a license to this product for any other use, contact Molecular Probes, Inc., Business Development, 29851 Willow Creek Road, Eugene, OR 97402, USA, Tel: (541)465-8300. Fax: (541) 335-0504. Black Hole Quenchers®, BHQ-1® and BHQ-2® are trademarks of Biosearch Technologies, Inc. (BTI), and all BHQ products are licensed and sold under agreement with BTI. These products are sold exclusively for research and development use by the purchaser. They may not be used for any human or veterinary clinical or diagnostic purposes without express permission from BTI and they may not be re-sold, distributed, re-labeled or re-packaged. Cy™ Dyes and Cy™ -labeled oligonucleotides are covered by U.S. Patent Numbers 5,556,959 and 5,808,044 and are licensed and sold for non-commercial research purposes only. Any other use including diagnostic, therapeutic or in vivo applications requires a license from Amersham Biosciences, Inc. Cy™ is a trademark of Amersham Biosciences. FAM™, HEX™, ROX™, TAMRA™ and TET™ are trademarks of Applied Biosystems, Inc. Iowa Black™ , TYE™, MAX™, TEX™ 613 are trademarks of Integrated DNA Technologies, Inc. IRDye® 700 and IRDye® 800 are products manufactured under license from LI-COR® Biosciences, which expressly excludes the right to use this product in qPCR or AFLP applications. Molecular Beacons are licensed under patents owned by The Public Health Research Institute of the City of New York, Inc. and come with licensed rights for use only in the purchaser's research and development activities. Oyster® is a registered trademark of Denovo Biolabels, GmbH. Well-Red® Dyes: IDT manufactured oligonucleotides incorporating Well-Red® Dyes are made and sold under license from Beckman Coulter Inc., (BCI) for use exclusively with BCI instruments or BCI-approved instruments. All other uses are prohibited unless specifically and separately authorized by BCI. Notice: The 5' Nuclease Assay and other homogenous amplification methods used in connection with the Polymerase Chain Reaction ("PCR") process are covered by patents owned by Roche Molecular Systems, Inc. and F. Hoffman La-Roche Ltd ("Roche"). No license to use the 5' Nuclease Assay or any Roche patented homogenous amplification process is conveyed expressly or by implication to the purchaser by the purchase of the above listed products or any other IDT products. |
* Gene Knockdown | | Chimeric Antisense Oligos. In addition to the exclusive license under the University of Iowa Research Foundation patents, IDT is the sole oligonucleotide supplier licensed under several patents owned or presently controlled by ISIS Pharmaceuticals, Inc. to manufacture and sell Chimeric Antisense Oligonucleotides to universities and other non-profit institutions for research purposes. Certain design, sequence, scale and use restrictions may apply. IDT reserves the unlimited right to refuse any order for Chimeric Antisense Oligos. DNA-directed RNAi. Use of IDT oligos for DNA-Directed RNAi research is protected by patents co-owned by Benitec Australia Ltd., and licensed exclusively to Promega Corporation in the human field (excluding human therapeutics). For information regarding licensing of ddRNAi technology, please visit www.promega.com/licensing. For licensing any human therapeutic purpose, contact Benitec Australia Ltd at info@benitec.com. Locked Nucleic Acids (LNAs). IDT is licensed under patents and patents applications assigned to Exiqon A/S to sell oligonucleotides incorporating LNAs for research purposes only. Resale of LNA-oligos and their use in humans or in therapeutic applications are all prohibited. RNAi. IDT's products are licensed under U.S. and international patent rights owned by the Carnegie Institution of Washington that cover RNA interference. These products are accompanied by a limited non-exclusive worldwide license under the Carnegie Institution of Washington's patent rights for researchers at academic or other not-for-profit institutions to use the products for non-profit research. However, use of dsRNA for RNA interference by for-profit organizations require a license from the Carnegie Institution of Washington.
siRNA. This product is licensed under European Patents 1144623, 121945 and foreign equivalents from Alnylam Pharmaceuticals, Inc., Cambridge, USA and is provided only for use in academic and commercial research whose purpose is to elucidate gene function, including research to validate potential gene products and pathways for drug discovery and development and to screen non-siRNA based compounds (but excluding the evaluation or characterization of this product as the potential basis for a siRNA based drug) and not for any other commercial purposes. Information about licenses for commercial use (including discovery and development of siRNA-based drugs) is available from Alnylam Pharmaceuticals, Inc., 300 Third Street, Cambridge MA 02142, USA. Dicector™ and TriFECTa™ are trademarks of IDT. IDT is exclusively licensed under patents owned by the City of Hope and IDT to make and sell Dicector™ products for use in research and development. Use of Dicector™ products or technology in humans or for human or veterinary diagnostic, prophylactic or therapeutic purposes requires a separate license from City of Hope Medical Center. |
* Other Licenses | | Acrydite™. IDT is licensed under U.S. Patent Number 6,180,770, and 5,932,711 to sell oligos incorporating Acrydite™ modifications for use solely in the purchaser's own life sciences research and development activities. Resale, or use of this product in clinical or diagnostic applications, or other commercial applications, requires separate license from Matrix Technologies, Inc. Acrydite™ is a trademark of Matrix Technologies, Inc.
Digoxigenin is licensed by Roche Diagnostics GmbH. The use of digoxigenin technology to label nucleic acids is licensed under patents (EP 0 324 474, US 5.344.757, US 5.702.888, US 5.354.657, JP 1999884 and HK 1169) owned by Roche Diagnostics GmbH. For further information on products to label and detect digoxigenin-modified nucleic acids refer to www.roche-applied-science.com/dig/. Iso dC and Iso dG. IDT is licensed by Eragen Biosciences, Inc., under United States Patent Numbers 5,432,272; 6,001,983; 6,037,120; and 6,140,496, and other pending applications to sell oligonucleotides for non-commercial, research use in the life sciences research market. Plexor™ is a trademark of Promega Corporation. RNaseAlert™ compositions and methods are protected under U.S. Patent No. 6,773,885 and other pending IDT patent(s). RNaseAlert™ is a trademark of Ambion, Inc. Rapid HPLC™, Express DLP™, SameDay®, Hot Plate™, Ultramer™, Mini Gene™, and Ready Made Primers™, OligoCardTM , I-Linker™ , DNaseAlert™ are trademarks of Integrated DNA Technologies, Inc. StarFire® is a trademark of IDT, and its compositions and methods are protected under pending IDT patent(s). SAGE™ is a trademark of Genzyme Molecular Oncology. Purchase of IDT oligos does not confer to customer a license to perform SAGE™methods. For more information, contact Genzyme or Johns Hopkins University. Uni-Link™ is a trademark of Clontech Laboratories, Inc. |
|